AstraZeneca Hit With Pay-For-Delay Suit Over Seroquel XR

Law360 (August 2, 2019, 10:57 PM EDT) -- Drug distributor J.M. Smith Corp. slapped AstraZeneca with an antitrust lawsuit in New York federal court on Friday claiming the pharmaceutical giant paid off a pair of generic-drug makers to stave off rivals to its brand anti-psychotic drug.

According to the distributor's proposed class action, AstraZeneca struck deals with Handa Pharmaceuticals LLC and Accord Pharmaceuticals Inc. that induced the two generic-drug makers to hold off on launching their versions of Seroquel XR — AstraZeneca's prescription drug treatment for schizophrenia, bipolar disorder and depression — for five years.

In exchange, J.M. Smith said AstraZeneca committed to stall the launch of its own...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS